Abscint

Precirix

This biotechnology company develops precision radiopharmaceuticals using camelid single-domain antibodies to treat patients with various types of cancer.

Nuclidium

This clinical-stage company develops copper-based radiopharmaceuticals for the diagnosis and treatment of cancer patients.

Adiposs

This biotech company develops medical imaging contrast agents to detect early-stage body wasting for cancer and chronic disease patients.

Alpha-9 Theranostics

This clinical-stage biotechnology company develops targeted radiopharmaceuticals to treat cancer patients by delivering radiation directly to tumours while sparing healthy tissue.

Alpha-9

Alpha-9 Oncology develops targeted radiopharmaceuticals and imaging compounds for the treatment of patients with various types of cancer.

PreComb

This company develops a precision oncology platform using patient-derived microtumour models and automated analysis to predict drug responses for biopharmaceutical firms and clinical institutions.

Digistain

This company develops a diagnostic test using infrared spectroscopy to provide breast cancer recurrence-risk stratification for oncologists and multidisciplinary clinical teams.

Adcendo ApS

The company develops antibody-drug conjugates to treat patients with advanced solid tumors and cancers that have high unmet medical needs.